Zobrazeno 1 - 10
of 674
pro vyhledávání: '"Manousou P"'
Autor:
R. Forlano, L. Martinez-Gili, P. Takis, J. Miguens-Blanco, T. Liu, E. Triantafyllou, C. Skinner, R Loomba, M. Thursz, J. R. Marchesi, B.H. Mullish, P. Manousou
Publikováno v:
Gut Microbes, Vol 16, Iss 1 (2024)
ABSTRACTAberration of the “gut-liver axis” contributes to the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we use multi-omics to analyze the gut microbiota composition and metabolic profil
Externí odkaz:
https://doaj.org/article/1939502f166a4f319e35ca45cc3e68b2
Autor:
Imanol Duran, Joaquim Pombo, Bin Sun, Suchira Gallage, Hiromi Kudo, Domhnall McHugh, Laura Bousset, Jose Efren Barragan Avila, Roberta Forlano, Pinelopi Manousou, Mathias Heikenwalder, Dominic J. Withers, Santiago Vernia, Robert D. Goldin, Jesús Gil
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-20 (2024)
Abstract Cellular senescence is a stress response with broad pathophysiological implications. Senotherapies can induce senescence to treat cancer or eliminate senescent cells to ameliorate ageing and age-related pathologies. However, the success of s
Externí odkaz:
https://doaj.org/article/5c897b7121a9453294556dca1837ca68
Autor:
Charlotte Hateley, Antoni Olona, Laura Halliday, Matthew L. Edin, Jeong-Hun Ko, Roberta Forlano, Ximena Terra, Fred B. Lih, Raúl Beltrán-Debón, Penelopi Manousou, Sanjay Purkayastha, Krishna Moorthy, Mark R. Thursz, Guodong Zhang, Robert D. Goldin, Darryl C. Zeldin, Enrico Petretto, Jacques Behmoaras
Publikováno v:
EBioMedicine, Vol 103, Iss , Pp 105127- (2024)
Summary: Background: Obesity drives maladaptive changes in the white adipose tissue (WAT) which can progressively cause insulin resistance, type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated liver disease (MASLD). Obesity-mediated l
Externí odkaz:
https://doaj.org/article/f522db65b00f4ac6b5690aad31edc432
Autor:
David Sheridan, Jeremy F Cobbold, Jeremy W Tomlinson, William Alazawi, Richard Parker, Alice J Sitch, Fredrik Karpe, David Harman, Hamish Miller, Márta Korbonits, Philip N Newsome, Guruprasad Padur Aithal, Pinelopi Manousou, Wiebke Arlt, Matthew Neville, Michael Biehl
Publikováno v:
BMJ Open, Vol 14, Iss 1 (2024)
Introduction Non-alcoholic fatty liver disease (NAFLD) affects approximately one in four individuals and its prevalence continues to rise. The advanced stages of NAFLD with significant liver fibrosis are associated with adverse morbidity and mortalit
Externí odkaz:
https://doaj.org/article/c214c03f55b64cb2948ce7f6c0914dce
Autor:
Wenhao Li, David Sheridan, Stuart McPherson, William Alazawi, Kush Abeysekera, Tom Marjot, Paul Brennan, Sara Mahgoub, Tessa Cacciottolo, Theresa Hydes, Tim Hardy, Gio McGinty, Oliver Tavabie, Jennifer Cathcart, Chirantha Premathilaka, Ashis Mukhopadhya, Arshiya Bhat, Shahnaz Begum, Bashar Abushaban, Meha Bhuva, Sophie Sinclair, Damien Leith, Cullen McCulloch, Joanna Leithead, Richard Fox, Muhammad Haris Shah, Eugene Campbell, Edward Brown, Dina Mansour, Fatma Shah, Michael Allison, Jonathan Chan, Victoria Roberts, Gautham Appanna, Mandour Omer Mandour, Georgina Slee, Vicki Wong, Sreelakshmi Kotha, Katrina Pekarska, Richard Parker, Cyril Sieberhagen, Thomas Ngan, Esra Asilmaz, Hamish Miller, Jeremy Cobbold, Dom Crocombe, Manolis Tsochatzis, Sudeep Tanwar, Aruna Dias, Gurmit Singh, Swastik Agrawal, Puneet Chhabra, Amrita Gurung, Rajesh Veettil, Robin Daniel Abeles, Devnandan Chatterjee, Michael Carbonell, Zameer Mohamed, Ahmed El-Sayed, Amy Johnson, Stephen Barclay, Katherine Kelly, Joshua Munonye, Dominic Coates, Opeyemi Bamidele, Thomas Johnston, David Samuel, Belinda Ball, Rebecca Arscott-Samuel, Pamela Hams, Matthew Armstrong, Ayman Elkhol, Karanth Shailesh, Vikram Bains, Pinelopi Manousou, Tarun Gupta, Sophia Than, Esther Unitt, Victoria Gordon, Alice Wakefield, Sian Gilchrist, Ioana Cozma, Sohaib Saeed, Salman Umrani, Kathryn Olsen
Publikováno v:
JHEP Reports, Vol 5, Iss 12, Pp 100897- (2023)
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is associated with liver and cardiovascular morbidity and mortality. Recently published NAFLD Quality Standards include 11 key performance indicators (KPIs) of good clinical care. This nati
Externí odkaz:
https://doaj.org/article/bb54d49e02c042e2b9089458eef64e89
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pei Chia Eng, Roberta Forlano, Tricia Tan, Pinelopi Manousou, Waljit S. Dhillo, Chioma Izzi-Engbeaya
Publikováno v:
JHEP Reports, Vol 5, Iss 10, Pp 100835- (2023)
Summary: Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide, affecting up to 30% of adults. Progression to non-alcoholic steatohepatitis (NASH) is a key risk factor for cirrhosis, hepatocellular carcinoma and cardio
Externí odkaz:
https://doaj.org/article/b65ab81e2c2148f3b2f5f6de245a6c7c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Efstathios Kastritis, Giovanni Palladini, Meletios A. Dimopoulos, Arnaud Jaccard, Giampaolo Merlini, Foteini Theodorakakou, Despina Fotiou, Monique C. Minnema Minnema, Ashutosh Wechalekar, Elena Papachristou, Kyriaki Manousou, Pieter Sonneveld, Stefan Schönland
Publikováno v:
HemaSphere, Vol 7, p e2301416 (2023)
Externí odkaz:
https://doaj.org/article/d89cfc6d848247d48726e4c02f808abb